Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Lithium for Prevention of First-episode Psychosis in Ultra High Risk Youth
NCT00202306Phase 4Completed
- Sponsor
- Melbourne Health
- Start
- Nov 2001
- Primary completion
- Dec 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of lithium carbonate in psychotic disorder, sponsored by Melbourne Health. Started Nov 2001; status: completed.
02
Drugs
lithium carbonate
03
Conditions
psychotic disorder
Beyond the preview
Go deeper on NCT00202306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00202306.